Author: Meghan Hosely

Meghan Hosely

Meghan is the Marketing Content Writer for Forte, and is an active contributor to Forte’s educational resources, including webinars, blog articles, eBooks and more.

Fireside Chat: The Future of Clinical Trials and Site Engagement

Fireside Chats, a new virtual series presented by Advarra, launches this month, bringing the research community together to discuss challenges and potential solutions.

Read more

Social Media’s Role in Clinical Research

Social media connects users worldwide, helping people stay connected. Its role in clinical research has many recruiting and retention benefits.

Read more

Q&A: The New Normal: Considerations for Restarting Research

In a recent webinar, Advarra IRB and research compliance experts discussed key areas to consider when ramping up research in the COVID-19 pandemic’s “new normal.”

Read more

Q&A: Gene Therapy Research in the Age of COVID-19: Study Startup for Infectious Disease, Oncology, and Rare Disease Research

In Advarra’s inaugural virtual symposium, experts from industry and academia met to discuss the unique challenges gene therapy research poses for research sites, sponsors, CROs, and study participants.

Read more

Improving Site-Sponsor Relationships Leads to Transparent Clinical Trials

The site-sponsor relationship is a multi-faceted one. The need for communication and understanding between the two is prevalent now more than ever.

Read more

Bringing the Gene Therapy Conversation to You – Virtually

On June 3, members of the research community gathered virtually to discuss updates on hot topics and emerging issues in gene therapy.

Read more

Patient Engagement and the IRB

The research community has increased patient and participant engagement, potentially impacting IRB review

Read more

For Sponsors and Sites, the Research Restart Effort Begins with Communication

The global pandemic has changed the way we think about research. Sponsors should consider how the “new normal” will impact sites and current studies as they plan to re-start research.

Read more

Finding a “New Normal” in Clinical Research

For much of 2020, COVID-19 has challenged “normal,” daily lives of many, but what does that mean for clinical research?

Read more

Safety Precautions for Laboratory Research With COVID-19 Specimens

Biosafety has surged to the spotlight due to the current COVID-19 global pandemic, motivating sites to conduct a risk assessment and develop a risk mitigation plan.

Read more

1 2 3 5